doi: 10.3389/fphar.2022.1030173 Received 28 August 2022 Accepted 05 October 2022 Published 17 October 2022 Volume 13 - 2022 Edited by Guangyue Su, Shenyang Pharmaceutical University, China Reviewed by Sherin Zakaria, Kafrelsheikh University, Egypt Hartmut Jaeschke, University of Kansas Medical Center Research Institute, United States Updates Copyright 2022 Shan, Wang, Zhai, Meng, Liu and Lv
" 2 NUTRITION SUPPORT FOR GLP-1 Therapy ~30% of body weight lost with GLP-1 RA based therapy is lean mass 1 Peak Australian diabetes and medical bodies, consider that "DSNFs may be a valuable consideration to enhancing overall protein and nutritional intake for individuals treated with GLP-1 Receptor Agonist (GLP-1a) medications who are at increased risk of lean muscle mass loss
Godon, O
Streamlining the Alzheimers diagnostic pathway: The role of biomarkers in ensuring accurate diagnosis and improving access to treatment
Peptides are short chains of amino acids that play key roles in various biological processes within the body
